Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.Kirkland, T.A., Adler, M., Bauman, J.G., Chen, M., Haeggstrom, J.Z., King, B., Kochanny, M.J., Liang, A.M., Mendoza, L., Phillips, G.B., Thunnissen, M., Trinh, L., Whitlow, M., Ye, B., Ye, H., Parkinson, J., Guilford, W.J.
(2008) Bioorg Med Chem 16: 4963-4983
- PubMed: 18394906
- DOI: 10.1016/j.bmc.2008.03.042
- Primary Citation of Related Structures:
3CHP, 3CHQ, 3CHR, 3CHS, 3CHO
- PubMed Abstract:
- Crystal Structure of Human Leukotriene A4 Hydrolase, a Bifunctional Enzyme in Inflammation
Thunnissen, M.M.G.M., Nordlund, P.N., Haeggstrom, J.Z.
(2001) Nat Struct Biol 8: 131
- Crystal structures of LEUKOTRIENE A4 HYDROLASE in complex with captopril and two competitive tight-binding inhibitors.
Thunnissen, M.M.G.M., Anderson, B., Samuelsson, B., Wong, C.-H., Haeggstrom, J.Z.
(2002) FASEB J 16: 1648
- Leukotriene A4 Hydrolase: Selective Abrogation of Leukotriene B4 Formation by Mutation of Aspartic Acid 375.
Rudberg, P.C., Tholander, F., Thunnissen, M.M., Samuelsson, B., Haeggstrom, J.Z.
(2002) Proc Natl Acad Sci U S A 99: 4215
- Leukotriene A4 Hydrolase: Identification of a Common Carboxylate Recognition Site for the Epoxide Hydrolase and Aminopeptidase Substrates
Rudberg, P.C., Tholander, F.O.T., Andberg, M., Thunnissen, M.M.G.M., Haeggstrom, J.Z.
(2004) J Mol Biol 279: 27376
Leukotriene B(4) (LTB(4)) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB(4) ...
Leukotriene B(4) (LTB(4)) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB(4) and possibly identify novel treatments, inhibitors of the LTB(4) biosynthetic enzyme, leukotriene A(4) hydrolase (LTA(4)-h), have been explored. Here we describe the discovery of a potent inhibitor of LTA(4)-h, arylamide of glutamic acid 4f, starting from the corresponding glycinamide 2. Analogs of 4f are then described, focusing on compounds that are both active and stable in whole blood. This effort culminated in the identification of amino alcohol 12a and amino ester 6b which meet these criteria.
Department of Medicinal Chemistry, Berlex Biosciences, 2600 Hilltop Drive, Richmond, CA 94804, United States. Thomas.email@example.com